BBH Top Holdings & Constituents
BBH, offered by VanEck, holds 25 reported positions across $400.0M in assets. Its largest holdings are Gilead Sciences Inc (GILD) (14.63%), Amgen Inc (AMGN) (14.54%), and Vertex Pharmaceuticals Inc (VRTX) (8.06%). The 5 biggest positions account for 50.02% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
GILD Gilead Sciences Inc | 14.63% | $54.37M |
AMGN Amgen Inc | 14.54% | $54.04M |
VRTX Vertex Pharmaceuticals Inc | 8.06% | $29.94M |
REGN Regeneron Pharmaceuticals Inc | 7.51% | $27.92M |
ARGX Argenx SE | 5.28% | $19.61M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Mar 31, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.